An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
2023 · Journal of Hepatology · 72 citations
https://doi.org/10.1016/j.jhep.2023.11.032
F
Floris F. van den Brand
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
411
Citations
9
h-index
9
i10-index
Floris F. van den Brand is an academic researcher from Amsterdam University Medical Centers. The author has contributed to research in topics: Liver Diseases and Immunity & Liver Disease Diagnosis and Treatment & Inflammatory Bowel Disease. The author has an h-index of 9, co-authored 18 publications.
ORCID: 0000-0002-5563-273XPapers by this author
worksAdverse events related to low dose corticosteroids in autoimmune hepatitis
2019 · Alimentary Pharmacology & Therapeutics · 61 citations
https://doi.org/10.1111/apt.15528
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry
2023 · Hepatology · 36 citations
https://doi.org/10.1097/hep.0000000000000589
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
2022 · Trials · 11 citations
https://doi.org/10.1186/s13063-022-06890-w
Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study
2021 · European Journal of Internal Medicine · 9 citations
https://doi.org/10.1016/j.ejim.2021.03.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat